health
Laromestrocel preprint reports effects in mild Alzheimer’s
A medRxiv preprint reports that laromestrocel reduced measures of brain inflammation and atrophy in 49 people with mild Alzheimer’s disease. The findings come from an early clinical study and have not yet been published as a peer-reviewed journal article.